Telemedicine Biz Can't Escape Investor Suit Over User Losses

By Jessica Corso · March 31, 2026, 6:41 PM EDT

A New York federal judge on Tuesday ruled Teladoc Health Inc. cannot escape an investor suit over its declining user base and increased advertising budget, saying the departure of its former...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Stary v. Teladoc Health, Inc. et al

Case Number

Court

New York Southern

Nature of Suit

Securities/Commodities

Date Filed

May 17, 2024

Recent Articles By Jessica

February 06, 2026
SEC Alleges Pharma Co. Misled Investors About Cancer Drug
December 23, 2025
AdaptHealth To Pay Investors $35M To End Inflated-Sales Suit
September 22, 2025
J&J Ruling Misapplied Goldman Precedent, 3rd Circ. Told
March 24, 2025
Kenvue, J&J Must Face Investor Suit Over FDA Concerns
December 03, 2024
SEC Says Biopharma's Cooperation Helped It Avoid Penalty
August 13, 2024
Judge Urged To Toss Novel Insider Trading Conviction
May 16, 2024
3rd Circ. Shuns Teva's 'Novel' Appeal On Israeli Investor Class
March 25, 2024
COVID 'Cure' Claims Can't Sustain Fraud Suit, 9th Circ. Rules
March 08, 2024
Judge Keeps Novel Insider Trading Indictment Alive
October 04, 2023
Justices Urged To Halt All In-House Cases Until Congress Acts